About Achillion Pharmaceuticals, Inc.
On January 28, 2020, Achillion Pharmaceuticals was acquired by Alexion Pharmaceuticals, Inc. As part of Alexion, we are continuing to advance a clinical-stage portfolio of orally administered factor D inhibitors and working toward the mission of transforming the lives of people with rare diseases.”
|
|
|
11-50 employees
View all Achillion Pharmaceuticals, Inc. employees
|
|
Pharmaceuticals
|
|
1777 Sentry Pkwy W, Blue Bell, Pennsylvania 19422, US
|
Achillion Pharmaceuticals, Inc. Alternatives
Frequently Asked Questions about Achillion Pharmaceuticals, Inc.
Who are the decision makers in Achillion Pharmaceuticals, Inc.?
The decision makers in Achillion Pharmaceuticals, Inc. are Becky Sendi Sendi, Benedict Osorio, Heather Robison, etc. Click to Find Achillion Pharmaceuticals, Inc. decision makers emails.
Achillion Pharmaceuticals, Inc. Staff Directory
Search Achillion Pharmaceuticals, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
